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Abstract Isolation and sequencing of a genomic clone encoding 
the mouse gene for the relaxin-like factor (RLF), which is 
endogenously expressed to a high level exclusively in Leydig 
cells, indicated that similar sequences were also present at the 3' 
end of the mouse JAK3 gene, a gene expressed predominantly in 
lymphoid tissues. More extensive Southern blot, polymerase 
chain reaction and sequencing analyses showed that the published 
mouse sequence for exon 23 of the JAK3 gene in fact comprises 
two exons, 23A and 23B, separated by an additional novel intron 
of 2.2 kb, and that within this intron the promoter and exon 1 of 
the mouse RLF gene are encoded. The two overlapping 
transcripts appear to use different polyadenylation signals in 
the common 3' untranslated region of exon 23B. Transient 
transfection of different RLF promoter reporter constructs into 
Leydig, Sertoli, granulosa and kidney cell lines indicate that as 
little as 0.7 kb of the region upstream of exon 1 of the RLF gene, 
and within the novel intron 22 of the JAK3 gene, is sufficient to 
account for cell-specific expression of the RLF gene. This 
promoter region is specifically hypomethylated in Leydig cells 
compared to non-expressing tissues. 
© 1997 Federation of European Biochemical Societies. 
Key words: JAK3; RLF; Leydig cell; Relaxin-like factor 
1. Introduction 
The relaxin-like factor (RLF), also referred to as the Leydig 
insulin-like (Ley-I-L) peptide, is a novel member of the insu-
lin/IGF/relaxin family of hormones and growth factors [1]. 
The mouse RLF cDNA encodes a 122 amino acid precursor 
polypeptide, comprising a signal peptide followed by B-, C-
and A-peptide domains [2], a structure similar to that of in-
sulin and relaxin. Although the function of RLF has not yet 
been elucidated, in all species where the cDNA sequence has 
been determined, there is a conserved motif within the B-do-
main, -R-X-V-L-R-, which is similar to the defined receptor 
binding motif for relaxin [3]. Indeed, a chemically synthesized 
human RLF peptide has been shown to interact specifically 
with relaxin receptors [4]. In all species studied so far, RLF 
appears to be expressed to a high level almost exclusively 
within the Leydig cells of the testis [1,2,5-7]. Recent studies 
also indicate varying levels of RLF gene expression in the 
ovary [5,6,8]. In the mouse testis, RLF expression is increased 
during puberty [2,8,9], though RLF mRNA can be detected 
by reverse transcription polymerase chain reaction (RT-PCR) 
as early as fetal day 13.5 p.c. [9]. 
All members of this family share a similar genomic struc-
ture with two exons interrupted by a single intron, with the 
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splice junction occurring within the open reading frame en-
coding the first part of the C- (connecting) peptide domain. In 
order to delimit and characterize the promoter region of the 
mouse RLF gene, and to understand the mechanisms ensuring 
the Leydig cell-specific pattern of expression, we have isolated 
and sequenced a genomic fragment cloned from a strain 129 
mouse genomic library. During the course of this study, a 
database search indicated homology between exon 2 of the 
mouse RLF gene and a part of exon 23 of the mouse JAK3 
genomic sequence (accession number U71201 [10]). Prelimi-
nary comparisons of the structural organization of the two 
genes were unable to provide a satisfactory explanation for 
this sequence identity. We therefore used a combination of 
Southern hybridization, PCR and sequencing strategies and 
showed that there is an additional intron within the published 
mouse JAK3 genomic sequence, which interrupts the pub-
lished exon 23 sequence, and that the promoter region, exon 
1 and intron of the mouse RLF gene are located within this 
novel intron. Thus the mouse RLF gene is located within the 
JAK3 cistronic domain and shares part of a downstream, 
protein-coding exon and 3' untranslated region. 
2. Materials and methods 
2.1. Isolation and sequencing of genomic clones 
Two RLF-specific primers, Rl (5'-CGCGCCGCTGCTACT-
GATGC) and R2 (5'-AGGGCCTGTGGTCTTGCTTACTGC) were 
designed based on the mouse RLF cDNA sequence [2], and corre-
sponding to exons 1 and 2 of the human and porcine genes. These 
were used in a PCR reaction employing standard conditions, to am-
plify a mouse genomic sequence. The resulting 1.2 kb PCR amplicon 
was sequenced, labelled with [a-32P]dCTP (Amersham-Biichler, 
Braunschweig, Germany) using the random primer method (Prime-
A-Gene Labelling Kit, Promega, Madison, WI), and used to screen 
approximately 5X105 clones of a mouse 129/SVJ genomic X library 
(Lambda-FIX II, Stratagene, Palo Alto, CA). A single positive clone 
was isolated and purified. Digestion of the bacteriophage DNA with 
Sail released an insert of approximately 5.5 kb, which was subcloned 
into the pBluescript KS II plasmid (Stratagene) for restriction map-
ping and sequence analysis. M13 and RLF-specific primers were used 
for cycle sequencing and the sequence data collated on an ABI 373 A 
automated sequencer (Perkin Elmer - Applied Biosystems, Foster 
City, CA). Sequence data were analysed using DNASTAR software, 
Madison, WI). 
In order to check the structural relationship of the RLF gene with 
the JAK3 gene, further PCR analysis was undertaken using mouse 
genomic DNA as template. A forward primer (J5, see Fig. 1; 5'-
CAGCCTTCGGCACCCTG) was designed based on a 5' sequence 
of the published exon 23 of the JAK3 gene [10]. As reverse primers, 
sequences were used derived from exons 1 and 2 of the RLF gene (see 
Fig. 1) (R2, as above; R3, 5'-GTCTCCACAGGCTGCGT; R4, 
GTTTGGGACACAGGGAGGAG; R5, ACCAGCGCGTGCAG-
GAGATGT). PCR was carried out for 30 cycles with the following 
conditions: 95°C, 2 min denaturing, then 95°C for 20 s denaturing, 
55°C for 40 s annealing, 72°C for 2 min 30 s extension, increasing by 
10 s/cycle from cycles 11 to 30. 
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2.2. Southern analysis of genomic DNA 
Twenty ¡xg of genomic DNA derived from the kidney of a male 
mouse were exhaustively digested overnight with 100 units of BamHI 
or Sail. Samples of 10 |ig were loaded in duplicate on to a 1.3% 
agarose gel, electrophoresed and transferred following standard pro-
cedures [11]. One of the duplicate membranes was probed with a 919 
bp Psil-specific fragment (Fig. 1) specific for exon 23 of the mouse 
JAK3 gene (nucleotides 8630^9549 [10]). The second duplicate mem-
brane was probed with a 474 bp RLF-specific probe (Fig. 1), which 
contains ca. 300 bp of the promoter region and exon 1 of the RLF 
gene, and was generated by PCR using primers R301 (5'-CCAAGCT-
TACAACCTAAACTGCCTCCAAC, including an artificial Hindlll 
site at the 5' end) and R3 (see above), with the 5.5 kb RLF genomic 
fragment (see above) as template. Probes were labelled as above, and 
hybridization performed at 65°C overnight [12]. Membranes were 
washed under increasingly stringent conditions (final: 65°C in 
0.1 XSSC/0.1% SDS) and exposed to Biomax film (Eastman Kodak, 
Rochester, NY) for 48 h. 
In order to detect whether the promoter region of the RLF gene 
might be differentially methylated in expressing compared to 
non-expressing tissues, 10 ug genomic DNA from either Percoll-puri-
fied mouse Leydig cells, spleen or liver, were digested overnight with 
100 units each of BamHI and Hpall, or BamHI and Mspl. Electro-
phoresis and blotting were performed as above. To compare the 
relative methylation patterns, the resulting blots were hybridized 
with the same 474 bp RLF-specific probe used above. Equal loading 
was verified by ethidium bromide staining of the completed gel (not 
shown). 
2.3. Transfection of cell lines with RLF promoter constructs 
Mouse Leydig (BLT-1 [13]), Sertoli (MSC-1 [14]), granulosa (KK-1 
[15]) and monkey kidney (COS-7) cells were cultured in Dulbecco's 
modified Eagle's medium/F12 (DMEM/F12; Gibco, Paisley, Scot-
land), supplemented with 10% heat-inactivated fetal calf serum (Bio-
clear, Berks, UK) and 0.1 g/1 gentamycin (Biological Industries, Bet-
Haemek, Israel). A second mouse Leydig cell line (mLTC-1 [16]) was 
cultured as described previously [17]. Firefly luciferase reporter gene 
constructs were ligated to 4.3 kb and 0.7 kb fragments of the putative 
mRLF promoter in the promoterless luciferase vector. Cell lines 
were transiently transfected in triplicate by electroporation using 
equal molarity (10 pmol) of promoterless, 0.7 kb RLF and 4.3 kb 
RLF luciferase expression constructs. pBluescript plasmid DNA was 
used as carrier to equalize the amount of transfected DNA [18]. 
A total of approximately 5X106 cells in serum- and antibiotic-free 
medium were electroporated in a Genepulser cuvette (0.4 cm gap, 
BioRad, Richmond, CA) by using 350 V/960 uF for BLT-1 cells; 
320 V/960 uF for LTC, KK-1 and MSC-1 cells; and 300 V/960 iiF 
for COS-7 cells. The electroporated cells were incubated for 24 h 
on 10 cm plates, before harvesting and analysis of luciferase activity 
[21]. Luciferase activity was measured using the 1251 luminometer 
(BioOrbit, Turku, Finland), and results corrected for transfection ef-
ficiency by relating to values for a cotransfected CMV-ß-galactosidase 
construct. 
3. Results 
3.1. Structural organization of the RLFIJAK3 gene locus 
By comparison with the cDNA sequence [2], and as indi-
cated in Fig. 1, the 5.5 kb San restriction fragment isolated 
from the RLF-positive bacteriophage clone of mouse genomic 
DNA included approximately 4.3 kb of the region upstream 
of exon 1 of the RLF gene. This is followed by an intron of 
740 bp and most of exon 2 up to, but not including the 
polyadenylation signal within the 3' untranslated region 
(UTR) of the RLF mRNA. Within exonic regions, there is 
full agreement with the cDNA sequence, with the 175 bp exon 
1 encoding the signal and B-peptide domains, as well as the 
first 7 amino acids of the C-domain. Exon 2 encodes the 
remainder of the C-domain, together with the A-peptide do-
main and part of the 3' UTR. 
Approximately 1500 bp of the 5' UTR and putative pro-
moter region upstream of the first ATG translation initiator 
codon was sequenced. There is a TATA-box 36 bp upstream 
of the ATG codon, and an Spl site about 15 nucleotides 
further upstream. Three putative binding sites for the tran-
scription factor steroidogenic factor —1 (SFl/Ad4BP [19,20]) 
are located at positions —64 to —57, —144 to —137 and —479 
to —472, relative to the ATG codon (Fig. 1). Additionally, 
there is a recognition motif for the sex determining region Y 
transcription factor (SRY [21,22]) at position —211 to —217. 
In addition to the immediate region of the RLF gene, also 
ca. 600 bp of the extreme 5' end of the SaR restriction frag-
ment were sequenced. A homology search showed this region 
to be 96% identical to nucleotides 6627-7219 of the published 
mouse JAK3 genomic sequence [10], corresponding to exon 
17, intron 17, and part of exon 18 of this gene. Further ho-
mology mapping showed that the sequence —1515 to —1095 
relative to the initiator codon of the RLF gene corresponded 
with 94% homology to nucleotides 9409-9829 of the JAK3 
gene, equivalent to part of exon 23. Further, exon 2 of the 
RLF gene shows 96.6% identity to the immediately following 
nucleotides 9830-10230 of the JAK3 gene, corresponding to 
the subsequent part of exon 23. There were no corresponding 
homologies to other parts of the mouse RLF gene sequence, 
such as exon 1 or the immediate upstream promoter. Assum-
ing the sequences of the mouse RLF and mouse JAK3 genes 
are indeed syngeneic, then the only plausible explanation is 
that the published JAK3 genomic sequence is incorrect, and 
Fig. 1. Schematic organization of the mouse JAK3/RLF gene locus, indicating relative positions of the JAK3 (hatched boxes) and RLF (open 
boxes) exons, positions of PCR primers used, and locations of potential transcription factor binding sites. Also shown above is the original 
JAK3 genomic structure (accession number U71201). For details, see text. 
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Fig. 2. Southern hybridization of mouse genomic DNA. A and B represent duplicate blots hybridized against RLF and JAK3 specific probes 
respectively. C: Genomic DNA from Leydig cells, spleen or liver, exhaustively digested with BamHl and either Hpall or Mspl, as indicated. 
The undigested 5.5 kb BamHl precursor fragment did not resolve from the slots in this short run gel (not included). The positions of DNA 
size markers are shown beside the panels. 
that the proposed exon 23 is in fact a composite of two exons 
separated by a substantial novel intron, which would also 
include exon 1 of the RLF gene, as reflected in the structure 
of our RLF genomic clone (Fig. 1). 
Two analyses were carried out to check this hypothesis. 
Firstly, PCR reactions were performed, using mouse genomic 
DNA as template and specific primers from the 5' portion of 
exon 23 of the JAK3 gene (J5; forward primer) and exons 
1 and 2 of the RLF gene (R2, R3, R4 and R5; reverse pri-
mers), R2 and R4 being equivalent to the 3' portion of exon 
23 of the JAK3 gene. The resulting products (not shown) of 
2.4, 1.3, 2.45 and 2.13 kb, respectively, imply the presence of 
ca. 2 kb of additional intronic sequence as predicted from the 
organization of the bacteriophage clone (Fig. 1). The validity 
of the PCR products was checked by DNA sequencing. Sec-
ondly, Southern hybridizations of genomic blots were per-
formed using RLF- and JAK3-specific probes (Fig. 2A and 
B). For the restriction enzymes employed (BamHl and Sail), 
an identical pattern was found for the two probes. This shows 
firstly that the restriction map predicted from the organization 
of the bacteriophage clone reflects the true genomic structure, 
the BamHl fragment being approximately 2 kb larger than is 
predicted from the published JAK3 genomic sequence, and 
that both genes are syngeneic as anticipated. 
lower luciferase activity than the 0.7 kb fragment. These re-
sults indicate that apparent full activity and specificity of the 
mouse RLF promoter probably reside within less than 0.7 kb 
of the upstream promoter region, that is, within the region 
defined above as intronic between exons 23A and 23B of the 
JAK3 gene (Fig. 1). 
3.3. Methylation analysis of genomic DNA in the RLF 
promoter region 
Genomic regions requiring access by transcription factors 
are characterized by a low level of methylation in tissues 
where a gene is being expressed by comparison with tissues 
where the gene is not expressed. Thus, in order to confirm that 
3.2. RLF gene promoter specificity and activity 
Transient transfection of the RLF promoter luciferase con-
structs showed that both the 4.3 kb and the 0.7 kb promoter 
constructs, compared to the promoterless construct, gave high 
(60-fold) specific luciferase activity in the two mouse Leydig 
cell lines, but none in the Sertoli cell line (Fig. 3). A similar 
high level of expression to that in the Leydig cell lines was 
also seen in the KK-1 murine granulosa cell line. Only a low 
basal activity (5-10-fold) was evident in the transfected COS-7 
cells. The 4.3 kb promoter construct indicated a marginally 
Fig. 3. Effect of two different RLF promoter constructs on the ac-
tivity of the luciferase reporter gene in different cell lines. The data 
shown represent the mean of triplicates from two independent ex-
periments (±S.E.M.). Post hoc statistical analysis used Fisher's 
PLSD, with the significance levels of differences from the expression 
of the promoterless luciferase construct set at *P<0.05, 
**p<o. = l, ***p<0.001. 
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the immediate upstream region from exon 1 of the RLF gene 
represents a probable gene promoter, tissue-specific differen-
tial methylation was assessed by comparing the restriction 
pattern obtained with the methylation-sensitive endonuclease 
Hpall, with that from its methylation-insensitive isoschizomer 
Mspl (Fig. 2C). The sequence data indicate that there are two 
Hpall/Mspl sites within the region covered by the specific 
probe used, yielding upon complete digestion a major frag-
ment of 578 bp, following preliminary cleavage with BamHl. 
In Leydig cells, Hpall digestion was as efficient as Mspl di-
gestion, showing that this region is relatively unmethylated 
compared to tissues which do not express the RLF gene, 
such as the spleen or liver where Hpall digestion was ineffi-
cient. 
4. Discussion 
The mouse JAK3 gene encompasses ca. 12 kb of genomic 
sequence, reportedly comprising 23 exons and 22 introns. In 
the mouse, there would appear to be several splice variants, 
resulting from alternative splicing in the 3' region [23]. To 
date, JAK3 expression has been described as predominantly 
in lymphoid tissue and is related to signal transduction in NK 
and T cells [24]. The RLF gene in contrast is small, compris-
ing two exons, with a short intervening sequence, and has a 
length, excluding the upstream promoter of less than 2 kb. 
The RLF gene is characterized by a very specific tissue dis-
tribution, in the mouse being almost exclusively restricted to 
the testicular Leydig cells [2]. Other tissues in the mouse only 
indicate levels of expression detectable by RT-PCR tech-
niques. In the course of characterizing the mouse RLF gene, 
we identified regions of homology to segments of the 3' region 
of the mouse JAK3 gene. However, the experimentally deter-
mined organization of this genomic region did not tally with 
the published genomic sequence for mouse JAK3. Instead, we 
have been able to show that the published exon 23 of the 
JAK3 gene in fact includes a further intron of 2 kb, resulting 
in exons 23A and 23B. Exon 23B is syngeneic with exon 2 of 
the mouse RLF gene, using the same acceptor splice junction. 
This exon encompasses therefore both parts of the protein-
coding region of the RLF transcript and downstream 3' UTR, 
as well as the 3' UTR of the JAK3 transcript. There would 
appear to be a differential use of polyadenylation signals, 
since the RLF and JAK3 sequences defined by cDNA cloning 
have differing 3' UTRs. Exon 1 of the mouse RLF gene is 
located in the middle of the new intron 23 of the JAK3 gene 
and appears not be used in any of the splice variants pub-
lished for JAK3 in the mouse or rat. 
From the literature JAK3 and RLF appear to have discrete 
tissue distributions, the former predominantly in lymphoid 
tissues, with additional low expression in lung, kidney and 
intestine [25], the latter in testicular Leydig cells [2]. Both 
genes are expressed maximally in the adult organism. 
Transient transfection analysis of RLF promoter constructs 
indicated that sufficient information is contained within ap-
proximately only 0.7 kb of the 5' region upstream of the RLF 
exon 1, to encode both Leydig cell specificity and regulatory 
elements. Thus also the complete promoter for the mouse 
RLF gene would appear to be contained within intron 23 of 
the JAK3 gene. In general agreement with the mouse genomic 
sequence encoding RLF recently published by Zimmerman et 
al. [9], we also find motifs in the promoter region correspond-
189 
ing to the transcription factor SF-1, which is known to medi-
ate regulation of several genes in steroidogenic tissues [20]. 
Further experiments are necessary to determine which of these 
putative eis elements are used in vivo, and whether these alone 
are sufficient to explain both cell specificity and upregulation. 
However, the promoter region used for JAK3 expression 
would appear to be discrete from that for RLF, since the 
general pattern of tissue specificity is quite different. Further-
more, in Leydig cells, where the RLF gene is highly expressed, 
the RLF promoter sequence is markedly hypomethylated, 
whereas in tissues where this gene is not expressed the respec-
tive segment is considerably methylated (liver and spleen). The 
spleen, however, is a lymphoid tissue with moderate JAK3 
expression [25], suggesting that hypomethylation in intron 
22 is not needed for JAK3 gene expression. 
Recently, Safford et al. [26] reported that a similar colocal-
ization of the RLF (Ley-I-L) and JAK3 genes occurs on hu-
man chromosome 19pl2-13.1. Thus it would appear that this 
colocalization is not a uniquely murine event but is a feature 
which has been conserved through evolution. 
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